Overview

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Status:
Completed
Trial end date:
2009-04-06
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy of LDX treatment group compared to placebo on the change from Baseline ADHD-RS-IV score at endpoint.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Lisdexamfetamine Dimesylate